KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Cardlytics (CDLX) over the last 8 years, with Q3 2025 value amounting to $8.0 million.

  • Cardlytics' Treasury Shares rose 7107.79% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 7107.79%. This contributed to the annual value of $4.5 million for FY2024, which is 1783.04% down from last year.
  • Per Cardlytics' latest filing, its Treasury Shares stood at $8.0 million for Q3 2025, which was up 7107.79% from $7.3 million recorded in Q2 2025.
  • In the past 5 years, Cardlytics' Treasury Shares registered a high of $8.0 million during Q3 2025, and its lowest value of $6667.0 during Q3 2021.
  • Over the past 5 years, Cardlytics' median Treasury Shares value was $4.7 million (recorded in 2024), while the average stood at $3.9 million.
  • Per our database at Business Quant, Cardlytics' Treasury Shares plummeted by 9973.8% in 2021 and then surged by 7620118.49% in 2022.
  • Over the past 5 years, Cardlytics' Treasury Shares (Quarter) stood at $2.3 million in 2021, then surged by 159.63% to $6.0 million in 2022, then dropped by 7.91% to $5.5 million in 2023, then decreased by 17.83% to $4.5 million in 2024, then soared by 77.83% to $8.0 million in 2025.
  • Its Treasury Shares stands at $8.0 million for Q3 2025, versus $7.3 million for Q2 2025 and $6.3 million for Q1 2025.